Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance.
Inceptive
5 followers
Mineralys Therapeutics
3 followers
MapLight Therapeutics
3 followers
Immunome
2 followers
Bionova Scientific
2 followers
Immunic Therapeutics
1 follower
MedRhythms
1 follower
Phanes Therapeutics
1 follower
Centessa Pharmaceuticals
3 followers
Strand Therapeutics
3 followers
Nuvalent
2 followers
MBX Biosciences
2 followers